Genetic testing for inherited forms of breast cancer is currently available
to individuals who want to learn their genetic status for the BRCA1 and BR
CA3 genes. Although still largely limited to research programs, widespread
commercial testing and incorporation of genetic testing into primary care p
ractices will occur in the not too distant future. Despite the availability
of this technology, treatment and prevention strategies offered to these o
ften healthy women are limited and somewhat controversial. Due to the medic
al and emotional complexities associated with the gap between genetic infor
mation and treatment interventions, behavioral scientists are currently inv
estigating the psychosocial implications involved in genetic testing for th
e BRCA1/2 genes. This article attempts to summarize the current research mo
dels, and reviews the most recent findings of investigations evaluating the
emotional and behavioral implications associated with genetic testing for
breast cancer susceptibility.